Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

Analyst Ratings

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $2.10 (337.50% upside)

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetActions
2/29/2016S&P Equity ResearchBoost Price Target$1.80 -> $2.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Northwest Biotherapeutics (NASDAQ:NWBO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
11/19/2014Q314($0.35)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/20/2014($0.29)($0.53)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/21/2014($0.33)($0.46)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Northwest Biotherapeutics (NASDAQ:NWBO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.25)($0.25)($0.25)
Q2 20161($0.29)($0.29)($0.29)
Q3 20161($0.33)($0.33)($0.33)
Q4 20161($0.35)($0.35)($0.35)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Northwest Biotherapeutics (NASDAQ:NWBO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Northwest Biotherapeutics (NASDAQ:NWBO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Northwest Biotherapeutics (NASDAQ:NWBO)
DateHeadline
07/17/16 04:58 PMShares Experiencing a Downtrend: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - TGP
07/17/16 04:58 PMNorthwest Biotherapeutics, Inc. (NWBO) Broker Price Targets For The Coming Week - Fiscal Standard
07/17/16 04:58 PMNorthwest Biotherapeutics, Inc (NASDAQ:NWBO) Is In a Real Mess, But Are There Better Days To Come? - Insider Financial
07/15/16 10:27 AMNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During July 13 Session - Equities.com
07/12/16 05:51 PMNotable Buzzers: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) , Grifols, S.A. (NASDAQ:GRFS) - Street Updates
07/11/16 04:26 PMNORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an -
07/11/16 10:10 AMNews Buzz: Genocea Biosciences, Inc. (NASDAQ:GNCA), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), The ... - KC Register
07/06/16 10:09 AMTake a look at Analyst Tips: Gilead Sciences, Inc. (NASDAQ:GILD) , Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Street Updates
07/06/16 10:09 AMCompany Update (NASDAQ:NWBO): Northwest Biotherapeutics, Inc Announced a Registered Direct Offering of $3.7 ... - Smarter Analyst
07/05/16 08:21 AMNW Bio Announced a Registered Direct Offering of $3.7 Million With New Institutional Investors - [at noodls] - BETHESDA, Md., July 5, 2016 - Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it ...
07/05/16 08:01 AM9:01 am Northwest Biotherapeutics announces a $3.7 mln registered direct offering for 7.4 mln shares of common stock at $0.50/share -
07/05/16 08:00 AMNW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $3.7 MILLION WITH NEW INSTITUTIONAL INVESTORS - [PR Newswire] - BETHESDA, Md., July 5, 2016 /PRNewswire/ -- Northwest Biotherapeutics (NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that it has entered into definitive agreements with two new institutional investors for a registered direct offering with gross proceeds of $3.7 million. The Company will sell to the investors approximately 7.4 million shares of common stock at a purchase price of $.50 per share resulting in gross proceeds to the Company of $3.7 million. The investors will also receive warrants to purchase up to approximately 3.7 million shares of common stock with an exercise price of $.60 per share and an exercise period of 5 years.
07/02/16 08:21 AMNorthwest Biotherapeutics (NWBO) Announces 180-Day Grace Period Relating to Non-Compliance With Nasdaq Bid ... - StreetInsider.com
07/02/16 08:21 AMRecently Issued Stock Ratings For Northwest Biotherapeutics, Inc. (NWBO) - Fiscal Standard
06/30/16 04:25 PMNW Bio Enters First 180-Day Grace Period Relating To Non-Compliance With Nasdaq $1.00 Per Share Bid Requirement - [PR Newswire] - On June 24, 2016, Northwest Biotherapeutics, Inc. (the "Company") received a written notice (the "Notice") from Nasdaq Staff that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common stock has been below $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the Nasdaq listing of the Company's common stock. The Company has a period of 180 days, or until December 21, 2016, to regain compliance with the minimum bid price requirement.
06/30/16 04:22 PMNORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule -
06/29/16 05:26 PMNorthwest Biotherapeutics Inc. (NWBO) Jumps 6.43% on June 28 - Equities.com
06/29/16 08:24 AMUltragenyx Pharmaceutical : Pre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys
06/29/16 08:24 AMPre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys
06/26/16 10:05 AMNorthwest Biotherapeutics Inc. (NWBO) Jumps 18.36% on June 23 - Equities.com
06/22/16 05:28 PMNorthwest Biotherapeutics Inc. (NWBO) Drops 5.21% on June 21 - Equities.com
06/20/16 01:57 PMETF’s with exposure to Northwest Biotherapeutics, Inc. : June 20, 2016 -
06/20/16 07:11 AMNorthwest Biotherapeutics, Inc. (NWBO) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 09:46 AMNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During June 16 Session - Equities.com
06/13/16 08:15 AMNW Bio Announces Scientific Advisory Board - [PR Newswire] - The Company anticipates that the SAB will address a variety of novel issues at the forefront of immuno-oncology, including evaluations of new discoveries in basic and applied immunology, the growing interest in the field in regard to cancer vaccines, clinical trial priorities and designs for combination therapies, regulatory strategies (including accelerated pathways) and related matters. Dr. Cheever's research is focused on cancer immunotherapy, including T cell therapy and the development of cancer vaccines, especially for breast cancer. He co-founded an early biotech company developing cancer vaccines, and served as Vice President of Clinical Research and Medical Affairs for 8 years. In that capacity, he gained extensive experience with design and execution of cancer vaccine clinical trials, FDA related product approval issues and collaboration with major pharmaceutical companies.
06/09/16 08:30 AMNorthwest Biotherapeutics Inc. (NWBO) Drops 9.89% on June 07 - Equities.com
06/08/16 09:19 AM[$$] Neil Woodford eyes new equity fund launch - [at Financial Times] - Star manager Neil Woodford is planning to launch a second equity fund for retail investors with the scope to invest across global stock markets to hit higher return targets. Woodford Investment Management ...
06/08/16 08:32 AMNorthwest Biotherapeutics Inc. (NWBO) is Trading Higher on Unusual Volume for June 06 - Equities.com
06/07/16 05:46 PMAnalysts Rating Alert: Mylan N.V. (NASDAQ:MYL) , Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Street Updates
06/07/16 05:46 PMEarnings Review: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), Ares Capital Corporation (NASDAQ:ARCC) - Beacon Chronicle
06/07/16 05:46 PMPerformance to see: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - News Oracle
06/06/16 05:29 PMAnalysts Rating Alert: Allergan plc. (NYSE:AGN) , Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Street Updates
06/06/16 04:38 PMETF’s with exposure to Northwest Biotherapeutics, Inc. : June 6, 2016 -
06/06/16 09:13 AMRecent Analysts Rating Alert: Allergan (AGN) , Northwest Biotherapeutics, (NWBO) - Street Updates
06/03/16 08:26 AMNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During June 01 Session - Equities.com - Northwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During June 01 SessionEquities.comNorthwest Biotherapeutics Inc. (NWBO) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.76, Northwest Biotherapeutics Inc. dropped to $0.74 for a new 52-week low. By the closing bell, the ...
05/27/16 10:43 PMNorthwest Biotherapeutics Inc. (NWBO) Drops 5.41% on May 26 - Equities.com - Northwest Biotherapeutics Inc. (NWBO) Drops 5.41% on May 26Equities.comNorthwest Biotherapeutics Inc. (NWBO) was one of the Russell 2000's biggest losers for Thursday May 26 as the stock slid 5.41% to $0.79, a loss of $-0.0452 per share. Starting at an opening price of $0.84 a share, the stock traded between $0.78 and $0 ...and more »
05/24/16 02:27 PMETF’s with exposure to Northwest Biotherapeutics, Inc. : May 24, 2016 -
05/23/16 11:58 AMNorthwest Biotherapeutics, Inc. :NWBO-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 -
05/21/16 08:41 AMNorthwest Biotherapeutics Inc. (NWBO) Drops 9.91% on May 19 - Equities.com - Northwest Biotherapeutics Inc. (NWBO) Drops 9.91% on May 19Equities.comNorthwest Biotherapeutics Inc. (NWBO) was one of the Russell 2000's biggest losers for Thursday May 19 as the stock slid 9.91% to $0.77, a loss of $-0.0851 per share. Starting at an opening price of $0.85 a share, the stock traded between $0.76 and $0 ...and more »
05/21/16 08:41 AMNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During May 19 Session - Equities.com - Northwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During May 19 SessionEquities.comNorthwest Biotherapeutics Inc. (NWBO) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.85, Northwest Biotherapeutics Inc. dropped to $0.76 for a new 52-week low. By the closing bell, the ...and more »
05/20/16 10:24 PMNorthwest Biotherapeutics, Inc. (NASDAQ:NWBO) One-Year Price Projection At $8 - RealistInvestor.com - Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) One-Year Price Projection At $8RealistInvestor.comSell-side analysts are certain on the prospect of Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) stock. As of 2016-05-19, the stock ABR stands at 1. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in ...and more »
05/19/16 05:23 PMHealthcare's Loser of the past Week: Northwest Biotherapeutics, Inc.'s (NWBO) - Is stories - Healthcare's Loser of the past Week: Northwest Biotherapeutics, Inc.'s (NWBO)Is storiesNorthwest Biotherapeutics, Inc.'s (NWBO) witnessed a loss of -3.93% in recent trading period with closing price of $ 0.86. The company's last traded volume of 0.48 million shares was above it's an average volume of 0.56 million shares. In the trailing ...and more »
05/18/16 05:18 PMNorthwest Biotherapeutics, Inc (NASDAQ:NWBO) Performance Overview - News Oracle - News OracleNorthwest Biotherapeutics, Inc (NASDAQ:NWBO) Performance OverviewNews OracleBy looking at Northwest Biotherapeutics, Inc (NASDAQ:NWBO) YTD (year to date) performance, the stock shows Negative value of -72.07%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the ...Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Reports Basic Consolidated EPS At $-1.4765Vanguard Tribuneall 3 news articles »
05/18/16 09:27 AMNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During May 16 Session - Equities.com - Northwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During May 16 SessionEquities.comNorthwest Biotherapeutics Inc. (NWBO) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.00, Northwest Biotherapeutics Inc. dropped to $0.83 for a new 52-week low. By the closing bell, the ...
05/17/16 10:16 PMNorthwest Biotherapeutics Inc. (NWBO) Drops 10.73% on May 16 - Equities.com - Northwest Biotherapeutics Inc. (NWBO) Drops 10.73% on May 16Equities.comNorthwest Biotherapeutics Inc. (NWBO) was one of the Russell 2000's biggest losers for Monday May 16 as the stock slid 10.73% to $0.86, a loss of $-0.103 per share. Starting at an opening price of $1.00 a share, the stock traded between $0.83 and $1.00 ...
05/15/16 05:45 PMAfter Last Week What Do Analysts Think Of Northwest Biotherapeutics, Inc. (NWBO) - Share Trading News - After Last Week What Do Analysts Think Of Northwest Biotherapeutics, Inc. (NWBO)Share Trading NewsThe share price of Northwest Biotherapeutics, Inc. (NWBO) was down -1.03% during the last trading session, with a day high of 1.05. 987698 shares were traded on Northwest Biotherapeutics, Inc.'s last session. The stock's 50 day moving average is 1.45 ...
05/14/16 03:51 AMNorthwest Biotherapeutics Inc. (NWBO) is Trading Lower on Unusual Volume for May 12 - Equities.com - Northwest Biotherapeutics Inc. (NWBO) is Trading Lower on Unusual Volume for May 12Equities.comNorthwest Biotherapeutics Inc. (NWBO) experienced unusually high volume on May. 12, as the stock lost 11.82% to a closing price of $0.97. The stock saw 1.27 million shares trade hands over the course of the day on 3,823 trades. Given that the stock's ...
05/13/16 05:35 PMNorthwest Biotherapeutics, Inc. (NASDAQ:NWBO) Latest Impact Score At 0 - RealistInvestor.com - Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Latest Impact Score At 0RealistInvestor.comNorthwest Biotherapeutics, Inc. (NASDAQ:NWBO) has a 0 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published ...and more »
04/08/16 03:58 PMETF’s with exposure to Northwest Biotherapeutics, Inc. : April 8, 2016 -
04/07/16 01:13 PMPenny Stocks To Watch: Thursday's List of Trending Small Cap Stocks April 7th - [Accesswire] - MIAMI, FL / ACCESSWIRE / April 7, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. AMRN, CBAY, RXMD, and NWBO have been added to our watch list today. Continue reading to find out ...

Social

About Northwest Biotherapeutics

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NWBO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.48
  • 50 Day Moving Average: $0.59
  • 200 Day Moving Average: $1.39
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $48.84M
  • Beta: 2.19
  • Current Year EPS Consensus Estimate: $-1.23 EPS
  • Next Year EPS Consensus Estimate: $-0.69 EPS
Additional Links:
Northwest Biotherapeutics (NASDAQ:NWBO) Chart for Sunday, July, 24, 2016